BCV
EVH icon

Banque Cantonale Vaudoise’s Evolent Health EVH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-778
Closed -$3K – 889
2025
Q4 		$3K Hold
778
– – ﹤0.01% 810
2025
Q3 		$7K Sell
778
-1,898
-71% -$18.4K ﹤0.01% 791
2025
Q2 		$30K Hold
2,676
– – ﹤0.01% 705
2025
Q1 		$25K Buy
+2,676
New +$27K ﹤0.01% 755
2024
Q3 		$76K Hold
2,676
– – ﹤0.01% 582
2024
Q2 		$51K Hold
2,676
– – ﹤0.01% 794
2024
Q1 		$88K Buy
+2,676
New +$85.4K ﹤0.01% 688
2022
Q1 		– Sell
-22,934
Closed -$635K – 1334
2021
Q4 		$635K Buy
+22,934
New +$658K 0.02% 517

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Cantonale Vaudoise's EVH Position: Q1 2026 in Review

Banque Cantonale Vaudoise sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 778 shares — an estimated $3K sold.

Banque Cantonale Vaudoise first reported a position in EVH in Q4 2021 and held it in 8 quarters. The position peaked at $635K in Q4 2021. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Banque Cantonale Vaudoise reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 778 Evolent Health shares in Q1 2026, an estimated $3K.
  • Banque Cantonale Vaudoise first reported a position in Evolent Health in Q4 2021 and held it in 8 quarters.
  • Banque Cantonale Vaudoise's Evolent Health position peaked at $635K in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.